MSCs |
To identify the exosomal microRNA profiles in different osteogenic differentiation stages of MSCs |
miR-31, miR-221, and miR-144 were decreased in exosomes from the late stage of osteogenic differentiation; miR-21 was upregulated. |
miR-31: Osterix (Osx) and special AT-rich sequence-binding protein 2 (Satb2); miR-221: Runx2; miR-144; Smad4; miR-21: pry1, Sox2, Smad7 |
Exosomes derived from hMSCs induce osteogenic differentiation of hMSCs in a stage-dependent manner |
— |
Myoblast |
To study the cross-talk between muscle and bone |
miR-27a-3p |
Apc, a negative regulator of b-catenin; Atf3 |
Myoblast exosomes affect the osteogenic differentiation of preosteoblasts |
|
Preosteoblasts |
To elucidate the effect of exosomal miRNAs on preosteoblast differentiation |
Let-7 miRNA |
The high-mobility group AT-hook 2 (Hmga2) |
Exosomes whose let-7 was inactivated efficiently lost their osteogenic differentiation capacity. |
|
Osteoblasts |
To study the effect of the exosomes derived from mineralizing osteoblasts on the osteogenic differentiation of MSCs. |
miR-667-3p, miR-6769b-5p, miR-7044-5p, miR-7668-3p, and miR-874-3p |
Axin1, an important negative regulator of Wnt signaling pathway |
Exosomes from MC3T3- E1 under 21 days of osteogenesis induction promote bone marrow stromal cell differentiation to osteoblasts |
|
BMSCs |
To identify the miRNA profile in exosomes derived from aged mice |
miR-183 cluster (miR-96/-182/-183) |
Heme oxygenase-1 (Hmox1) |
Aged exosomes inhibit the osteogenic differentiation of BMSCs |
|
BMSC |
To study the underlying mechanism of MSCT ameliorating osteopenia in Fas-deficient-MRL/lpr mice |
miR-29b |
Dnmt1 |
Improved osteogenic differentiation of MSCs from systemic lupus erythematosus (SLE) model |
Infusing exosomes rescues osteoporotic phenotype |
Adipose mesenchymal stem cells (ASCs) |
To investigate whether exosomes derived from miR-375-overexpressing hASCs could enhance bone regeneration |
miR-375 |
Insulin-like growth factor-binding protein 3 (lgfbp3) |
Improved the osteogenic differentiation of hBMSCs |
Enhanced the bone regeneration in calvarial defect |
Multiple myeloma (MM)--MSCs |
To understand the myeloma-stroma interactions |
RUNX-AS1 |
Runx2 |
Exosomes from MM-MSCs impaired the osteogenic differentiation of MSCs |
Inhibitor of exosome secretion, prevented bone loss in MM |
BMSC |
To characterize the full small RNAome of MSC-produced exosomes |
5′ halves of tRNA |
Runx2, Sox11, Smad3 |
|
|